Stay updated on MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial

Sign up to get notified when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added and Revision: v3.4.1 has been removed.
    Difference
    0.1%
    Check dated 2026-02-13T12:13:01.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    This is a minor metadata update: the revisions history shows Revision: v3.4.1, replacing v3.4.0, with no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:14:36.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page history shows Revision v3.3.4 added and Revision v3.3.3 removed.
    Difference
    0.1%
    Check dated 2026-01-15T04:44:04.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    The page history shows an added Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link, along with a prior Revision: v3.3.2; These are admin-level updates to the page metadata/footer and do not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-24T15:00:15.000Z thumbnail image
  6. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added to the page history, replacing v3.2.0 and reflecting a platform/UI update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:45:06.000Z thumbnail image
  7. Check
    100 days ago
    Change Detected
    Summary
    The page no longer displays a government funding and operating status notice that appeared at the top; this change does not affect the study record or its data.
    Difference
    0.5%
    Check dated 2025-11-18T07:27:32.000Z thumbnail image

Stay in the know with updates to MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.